A Comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line

Artificial Cells, Nanomedicine and Biotechnology

Volumn 44, Issue 1, 2016, Pages 423-430

  Mirakabad, Fatemeh Sadat Tabatabaei ^a   Akbarzadeh, Abolfazl ^a   Milani, Morteza ^b   Zarghami, Nosratollah ^a   Taheri Anganeh, Mortaza ^a   Zeighamian, Vahideh ^a   Badrzadeh, Fariba ^a   Rahmati Yamchi, Mohammad ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; Curcumin; MTT assay; PLGA PEG

Indexed keywords

BIOCHEMISTRY; CELL CULTURE; CELLS; CYTOTOXICITY; DRUG DELIVERY; NANOPARTICLES;

ANTICANCER EFFECTS; AQUEOUS SOLUBILITY; BREAST CANCER; CURCUMIN; MCF-7 BREAST CANCER CELLS; MCF-7 HUMAN BREAST CANCER CELLS; MTT ASSAYS; PLGA PEGS;

DISEASES;

CURCUMIN; MACROGOL; POLYGLACTIN; ANTINEOPLASTIC AGENT; DRUG CARRIER; LACTIC ACID; MACROGOL DERIVATIVE; NANOPARTICLE; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; IN VIVO STUDY; MCF 7 CELL LINE; NANOENCAPSULATION; NANOPHARMACEUTICS; PH; TEMPERATURE; CELL SURVIVAL; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECTS; DRUG FORMULATION; DRUG RELEASE; FEMALE; MCF-7 CELL LINE; PARTICLE SIZE; SYNTHESIS; ULTRASTRUCTURE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL SURVIVAL; CURCUMIN; DRUG CARRIERS; DRUG COMPOUNDING; DRUG LIBERATION; FEMALE; HUMANS; INHIBITORY CONCENTRATION 50; LACTIC ACID; MCF-7 CELLS; NANOPARTICLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID;

EID: 84964335138     PISSN: 21691401     EISSN: 2169141X     Source Type: Journal    
DOI: 10.3109/21691401.2014.955108     Document Type: Article

References (42)

1. Abbasi E, Aval SF, Akbarzadeh A, Milani M, Nasrabadi HT, Joo SW, Hanifehpour Y, Nejati-Koshki K, et al. 2014a. Dendrimers: synthesis, applications and properties. Nanoscale Res Lett. 9: 247.
2. Abbasi E, Milani M, Aval SF, Kouhi M, Akbarzadeh A, Nasrabadi HT, et al. 2014b. Silver nanoparticles: synthesis, properties, bioapplications and limitations. Crit Rev Microbiol. 1-8.
3. Ahmadi A, Shirazi H, Pourbagher N, Akbarzadeh A, Omidfar K. 2014. An electrochemical immunosensor for digoxin using core-shell gold coated magnetic nanoparticles as labels. Mol Biol Rep. 41: 1659-1668.
4. Akbarzadeh A, Mikaeili H, Zarghami N, Mohammad R, Barkhordari A, Davaran S. 2012a. Preparation and in-vitro evaluation of doxorubicin-loaded Fe3O4 magnetic nanoparticles modified with biocompatible copolymers. Int J Nanomedicine. 7: 511-526.
5. Akbarzadeh A, Nejati-Koshki K, Soghrati MM, Alimohammadi S, Ghamari MF, Davaran S. 2013a. In vitro studies of NIPAAM-MAA-VP copolymer-coated magnetic nanoparticles for controlled anticancer drug release. J Encapsulation Adsorpt Sci. 3: 108-115.
6. Akbarzadeh A, Rezaei A, Nejati-Koshki K, Alimohammadi S, Davaran S. 2014. Synthesis and physicochemical characterization of biodegradable star-shaped poly lactide-co-glycolide-β-cyclodextrin copolymer nanoparticles containing albumin. Adv Nanoparticles. 3: 14-22.
7. Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, et al. 2013b. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 8: 102.
8. Akbarzadeh A, Samiei M, Davaran S. 2012b. Magnetic nanoparticles: preparation, physical properties and applications in biomedicine. Nanoscale Res Lett. 7: 144-157.
9. Akbarzadeh A, Zarghami N, Mikaeili H, Asgari D, Goganian AM, Khiabani HK, Davaran S. 2012d. Synthesis, characterization and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin. Int J Nanotechnol Sci Environ. 5: 13-25.
10. Akbarzadeh A, Samiei M, Joo SW, Anzaby M, Hanifehpour Y, Nasrabadi HT, Davaran S. 2012c. Synthesis, characterization and in vitro studies of doxorubicin-loaded magnetic nanoparticles grafted to smart copolymers on A549 lung cancer cell line. J Nanobiotechnol. 10: 46.
11. Alimirzalu S, Akbarzadeh A, Abbasian M, Alimohammadi S, Davaran S, Hanifehpour Y, et al. 2014. Synthesis and study of physicochemical characteristics of Fe3O4 magnetic nanocomposites based on poly(Nisopropylacrylamide)for anti-cancer drugs delivery. Asian Pac J Cancer Prev. 15: 49-54.
12. Alizadeh E, Zarghami N, Baghaban Eslaminejad MR, Akbarzadeh A, Jahangir S, Barzegar A, et al. 2014. The effect of dimethyl sulfoxide on hepatogenic differentiation of mesenchymal stem cells. Int J Pediatr. (2): 57-58.
13. Anand P, Nair HB, Sung B, Kunnumakkara AB, Yadav VR, Tekmal RR, Aggarwal BB. 2010. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem Pharmacol. 79: 330-338.
14. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. 2008. Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer lett. 267: 133-164.
15. Anganeh MT, Sadat Tabatabaei Mirakabad F, Izadi M, Zeighamian V, Badrzadeh F, Salehi R, et al. 2014. The comparison between effects of free curcumin and curcumin loaded PLGA-PEG on telomerase and TRF1 expressions in calu-6 lung cancer cell line. Int J Biosci. 4: 134-145.
16. Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V. 2012. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 161: 505-522.
17. Davoudi Z, Akbarzadeh A, Rahmatiyamchi M, Movassaghpour AA, Alipour M, Nejati-Koshki K, et al. 2014. Molecular target therapy of Akt and NF-kB signaling pathways and multidrug resistanceby specific cell penetrating inhibitor peptides in HL-60 cell line. Asian Pac J Cancer Prev. 9: 4353-4358.
18. Dinarvand R, Sepehri N, Manoochehri S, Rouhani H, Atyabi F. 2011. Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. Int J Nanomedicine. 6: 877-895.
19. Eatemadi A, Daraee H, Zarghami N, Melat Yar H, Akbarzadeh A, Hanifehpour Y. 2014. Nanofiber: synthesis and biomedical applications. Artif Cells Nanomed Biotechnol. 1-11.
20. Ebrahimnezhad Z, Zarghami N, Keyhani M, Amirsaadat S, Akbarzadeh A, Rahmati M. 2013. Inhibition of hTERT gene expression by silibinin-loaded PLGA-PEG-Fe3O4 in T47D breast cancer cell line. BioImpacts. 3: 67-74.
21. Ghasemali S, Nejati-Koshki K, Tafsiri E, Rahmati-Yamchi M, Akbarzadeh A, Alizadeh E, et al. 2013. Study of inhibitory effect of β-cyclodextrin-helenalin complex on HTERT gene expression in T47D breast cancer cell line by real time quantitative PCR (q-PCR). Asian Pac J Cancer Prev. 14: 6949-6953.
22. Hosseininasab S, Pashaei-Asl R, Khandaghi AA, Nasrabadi HT, Nejati-Koshki K, Akbarzadeh A, et al. 2014. Synthesis, characterization, and In vitro studies of PLGA-PEG nanoparticles for oral Insulin delivery. Chem Biol Drug Design. 84: 307-315.
23. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. 2011. Global cancer statistics. CA Cancer J Clin. 61: 69-90.
24. Kouhi M, Vahedi A, Akbarzadeh A, Hanifehpour Y, Joo SW. 2014. Investigation of quadratic electro-optic effects and electro absorption process in GaN/AlGaN spherical auantum dot. Nanoscale Res Lett. 9: 1-6.
25. Liu J, Chen S, Lv L, Song L, Guo S, Huang S. 2013. Recent progress in studying curcumin and its nano-preparations for cancer therapy. Curr Pharm Des. 19: 1974-1993.
26. Mahapatro A, Singh DK. 2011. Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J Nanobiotechnology. 9: 55.
27. McPherson K, Steel C, Dixon J. 2000. ABC of breast diseases: breast cancer-epidemiology, risk factors, and genetics. BMJ. 321: 624.
28. Mollazade M, Nejati-Koshki K, Akbarzadeh A, Zarghami N, Nasiri M, Jahanban-Esfahlan R, Alibakhshi A. 2013. PAMAM den-drimers arugment inhibitory effect of curcumin on cancer cell proliferation: possible inhibition of telomerase. Asian Pac J Cancer Prev. 14: 6925-6928.
29. Nejati-Koshki K, Akbarzadeh A, Pourhasan-Moghadam M, Joo SW. 2013. Inhibition of leptin and leptin receptor gene expression by silibinin-curcumin combination. APJCP. 14: 6595.
30. Pourhassan-Moghaddam M, Rahmati-Yamchi M, Akbarzadeh A, Daraee H, Nejati-Koshki K, Hanifehpour Y, Joo SW. 2013. Protein detection through different platforms of immuno-loop-mediated isothermal amplification. Nanoscale Res Lett. 8: 485.
31. Pourhassan-Moghaddam M, Zarghami N, Mohsenifar A, Rahmati-Yamchi M, Gholizadeh D, Akbarzadeh A, et al. 2014. Watercress-based gold nanoparticles: biosynthesis, mechanism of formation and study of their biocompatibility in vitro. Micro Nano Lett. 9: 345-350.
32. Rasul A, Parveen S, Ma T. 2012. Costunolide: A novel anti-cancer sesquiterpene lactone. Bangladesh J Pharmacol. 7: 6-13.
33. Rezaei-Sadabady R, Zarghami N, Barzegar A, Eidi A, Akbarzadeh A, Rezaei-Tavirani M. 2013. Studies of the relationship between structure and antioxidant activity in interesting systems, including tyrosol, hydroxytyrosol derivatives indicated by quantum chemical calculations. Soft. 2: 13-18.
34. Sadat Tabatabaei Mirakabad F, Akbarzadeh A, Zarghami N, Zeighamian V, Rahimzadeh A, Alimohammadi S. 2014a. PLGA-cased nanoparticles as cancer drug delivery systems. Asian Pac J Cancer Prev. 15: 517-535.
35. Sadat Tabatabaei Mirakabad F, Nejati-Koshki K, Akbarzadeh A, Yamchi MR, Milani M, Zarghami N, et al. 2014b. PLGA-based nanoparticles as cancer drug delivery systems. Asian Pac J Cancer Prev. 15: 517-535.
36. Sadeghi-Aliabadi H, Ahmadi A. 2000. Cytotoxicity and antitumor properties of a marine compound on cancer cells (HESA-A). Med J Islam Acad Sci. 13: 55-61.
37. Shaikh J, Ankola DD, Beniwal V, Singh D, Kumar MN. 2009. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci. 37: 223-230.
38. Singh R, Lillard JW Jr 2009. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 86: 215-223.
39. Valizadeh A, Mikaeili H, Samiei M, Farkhani SM, Zarghami N, Kouhi M, et al. 2012. Quantum dots: synthesis, bioapplications, and toxicity. Nanoscale Res Lett. 7: 276.
40. Verderio P, Bonetti P, Colombo M, Pandolfi L, Prosperi D. 2013. Intracellular drug release from curcumin-loaded PLGA nanoparticles induces G2/M block in breast cancer cells. Biomacromolecules. 14: 672-682.
41. Yallapu MM, Gupta BK, Jaggi M, Chauhan SC. 2010. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J Colloid Interface Sci. 351: 19-29.
42. Zhou QM, Wang XF, Liu XJ, Zhang H, Lu YY, Su SB. 2011. Curcumin enhanced antiproliferative effect of mitomycin C in human breast cancer MCF-7 cells in vitro and in vivo. Acta Pharmacol Sin. 32: 1402-1410.